138 related articles for article (PubMed ID: 20545686)
1. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?
Langan EA; Nie Z; Rhodes LE
Br J Dermatol; 2010 Sep; 163(3):451-5. PubMed ID: 20545686
[TBL] [Abstract][Full Text] [Related]
2. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract][Full Text] [Related]
3. Alpha-melanocyte stimulating hormone analogues: the perils and the promise.
Mazza JM; Zippin JH
J Drugs Dermatol; 2009 Aug; 8(8):772-6. PubMed ID: 19663117
[No Abstract] [Full Text] [Related]
4. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.
Haylett AK; Nie Z; Brownrigg M; Taylor R; Rhodes LE
Br J Dermatol; 2011 Feb; 164(2):407-14. PubMed ID: 20969564
[TBL] [Abstract][Full Text] [Related]
5. An in-depth case examination of an exotic dancer's experience of melanotan.
Van Hout MC; Brennan R
Int J Drug Policy; 2014 May; 25(3):444-50. PubMed ID: 24280586
[TBL] [Abstract][Full Text] [Related]
6. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.
Dorr RT; Ertl G; Levine N; Brooks C; Bangert JL; Powell MB; Humphrey S; Alberts DS
Arch Dermatol; 2004 Jul; 140(7):827-35. PubMed ID: 15262693
[TBL] [Abstract][Full Text] [Related]
7. Pseudoleucoderma after injections of afamelanotide in a patient with atopic dermatitis.
von Bartenwerffer W; Siebenhaar G; Hunzelmann N
Acta Derm Venereol; 2011 Sep; 91(5):578-9. PubMed ID: 21597671
[No Abstract] [Full Text] [Related]
8. A review and update on melanocyte stimulating hormone therapy: afamelanotide.
Fabrikant J; Touloei K; Brown SM
J Drugs Dermatol; 2013 Jul; 12(7):775-9. PubMed ID: 23884489
[TBL] [Abstract][Full Text] [Related]
9. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E; Daly S; McKenna D
Dermatology; 2021; 237(6):995-999. PubMed ID: 34464955
[TBL] [Abstract][Full Text] [Related]
10. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
Cardones AR; Grichnik JM
Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
[TBL] [Abstract][Full Text] [Related]
11. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Habbema L; Halk AB; Neumann M; Bergman W
Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
[TBL] [Abstract][Full Text] [Related]
12. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
Harms JH; Lautenschlager S; Minder CE; Minder EI
Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
[TBL] [Abstract][Full Text] [Related]
13. [The Barbie drug melanotan--new internet drug with risky consequences].
Knudsen K; Kjergaard C; Dalhoff K
Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
[No Abstract] [Full Text] [Related]
14. A glimpse into the underground market of melanotan.
Callaghan Iii DJ
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.
Hadley ME; Dorr RT
Peptides; 2006 Apr; 27(4):921-30. PubMed ID: 16412534
[TBL] [Abstract][Full Text] [Related]
16. [The risks of tanning with the Barbie drug].
Eijmael MJPM; Janmaat CJ; Briët-Schipper EMN
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736369
[TBL] [Abstract][Full Text] [Related]
17. The unregulated use of melanotan-II is of public health interest to Australian dermatologists.
Adler NR; Dowling JP; Pan Y
Australas J Dermatol; 2017 Nov; 58(4):327-329. PubMed ID: 28905366
[No Abstract] [Full Text] [Related]
18. [Alpha-melanocyte-stimulating hormone. From bench to bedside].
Böhm M; Luger TA
Hautarzt; 2010 Jun; 61(6):497-504. PubMed ID: 20512306
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
Minder EI; Barman-Aksoezen J; Schneider-Yin X
Clin Pharmacokinet; 2017 Aug; 56(8):815-823. PubMed ID: 28063031
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of the melanocortin analogue Nle4-D-Phe7-α-MSH in acne vulgaris.
Böhm M; Ehrchen J; Luger TA
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):108-11. PubMed ID: 22845050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
